Particle.news

Download on the App Store

Pharmacies Curb COVID Shots After FDA Narrows Authorization to Seniors and High‑Risk Patients

State rules tied to CDC advisers are forcing prescription requirements at major chains.

Overview

  • The FDA cleared updated 2025–26 vaccines from Pfizer, Moderna and Novavax only for people 65 and older or younger patients with at least one qualifying medical condition.
  • CVS is requiring prescriptions in 13 states and Washington, D.C., and is not offering the shots in Massachusetts, Nevada and New Mexico, citing the current regulatory environment.
  • Walgreens says it will offer vaccinations where legally permitted, with many states requiring a clinician’s prescription until CDC advisory recommendations are issued.
  • In numerous states, pharmacist authority depends on ACIP guidance, insurers are waiting for the Sept. 18–19 ACIP meeting before finalizing coverage, and off‑label prescriptions may face practical and payment hurdles.
  • Illinois is exploring direct purchases from manufacturers, and a coalition led by Massachusetts is discussing coordinated pediatric supply plans should federal guidance restrict wider access.